Cefazolin vs Cloxacillin for Methicillin-Susceptible S aureus Bacteremia: A Meta-Analysis of 2 Randomized Clinical Trials
Year: 2026
Type: article
Abstract: This bayesian meta-analysis of 2 randomized clinical trials synthesizes mortality and safety outcomes associated with cloxacillin vs cefazolin for treatment of methicillin-susceptible S aureus bacteremia.
Source: JAMA Network Open
Authors: Todd C. Lee, Steven Y. C. Tong, Joshua S. Davis, Arthur M. Albuquerque, Matthew P. Cheng, Jacob Dye, Nesrin Ghanem-Zoubi, Anna L. Goodman, Nynke G. L. Jager, Achim J. Kaasch, Ilse J. E. Kouijzer, David C. Lye, Alistair R. D. McLean, Brendan J. McMullan, David L. Paterson, Connor Prosty, Jason A. Roberts, Pierre Tattevin, Jonas Tverring, Dafna Yahav, Emily G. McDonald
Institutions: McGill University, The Royal Melbourne Hospital, The University of Melbourne, Peter Doherty Institute, Hunter Medical Research Institute, University of Newcastle Australia, Universidade Federal do Rio de Janeiro, Federation University, UNSW Sydney, The George Institute for Global Health, Technion – Israel Institute of Technology, Rambam Health Care Campus, Guy's and St Thomas' NHS Foundation Trust, University College London, Radboud University Medical Center, Otto-von-Guericke-Universität Magdeburg, Radboud University Nijmegen, National University of Singapore, Nanyang Technological University, Tan Tock Seng Hospital, National Centre for Infectious Diseases, Sydney Children's Hospital, Sydney Children’s Hospitals Network, The University of Queensland, Royal Brisbane and Women's Hospital, Metro North Hospital and Health Service, Hôpital Pontchaillou, Helsingborgs lasarett, Sheba Medical Center
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,000
OpenAlex ID: W7225853545